Latest News

Wondering whether Palantir Technologies at around US$137 a share still makes sense for your portfolio, or if the price is running ahead of the story? The stock has been choppy recently, with a 1.5% decline over 7 days, an 8.7% decline over 30 days, and an 18.3% decline year to date, even though the 1 year return is 15% and the 3 year return is very large. Recent headlines have focused on Palantir’s role in data analytics for governments and enterprises, alongside ongoing debate about its...

Endesa (BME:ELE) opened Q1 2026 with revenue of €5.8b and basic EPS of €0.70, setting the tone for how investors will read the latest move in profitability. The company reported quarterly revenue of €5.8b in both Q1 2025 and Q1 2026, while EPS increased from €0.55 to €0.70 over the same period, providing a clearer view of how earnings are tracking against a broadly stable top line. With trailing net margins above last year and earnings growth running ahead of revenue, this update places...

Ingles Markets (IMKT.A) has put up a steady Q2 2026 print, with revenue at about US$1.3 billion and basic EPS of US$1.28, backed by trailing 12 month EPS of US$5.49 and net income of US$104.29 million. Over recent quarters the company has seen revenue move from roughly US$1.33 billion and EPS of US$0.80 in Q2 2025 to around US$1.31 billion and EPS of US$1.28 in the latest quarter. Over the same period, trailing net margin has lifted from 1.1% to 1.9%, giving you a set of results that point to...

Wondering whether Canadian Solar's share price still reflects its true worth, or if the market has moved ahead of the fundamentals? This article focuses squarely on what the current valuation might be telling you. After a period of sharp moves, with a 15.6% return over 7 days, 46.0% over 30 days, a 92.0% return over 1 year, and a year-to-date return of negative 30.4%, the stock has caught the eye of investors rethinking its risk and reward profile. These swings sit alongside a longer...

Fresh off its Q1 2026 report, Macerich (MAC) posted total revenue of US$231.7 million, a basic EPS loss of US$0.14, and funds from operations of US$92.4 million, keeping the focus firmly on cash generation rather than accounting earnings. Over recent quarters, total revenue has moved from US$339.2 million in Q4 2024 to US$248.4 million in Q1 2025, then to US$231.7 million in Q1 2026. Trailing twelve month EPS sits at a loss of US$0.72 alongside FFO of US$399.6 million, setting up a story...

Kontoor Brands (KTB) opened 2026 with Q1 revenue of US$613.3 million and basic EPS of US$1.11, alongside trailing 12 month revenue of about US$3.3 billion and EPS of US$5.02 that reflect the recent 20.6% earnings growth and an 8.3% net margin. Over the past year, the company has seen net income on a trailing 12 month basis move from US$245.8 million to US$278.2 million. During this period, quarterly revenue ranged from US$613.3 million to just over US$1.0 billion, while quarterly EPS ranged...

B2Gold (TSX:BTO) opened 2026 with Q1 revenue of US$1.2b and basic EPS of US$0.15, alongside net income of US$199.9 million. This followed a year in which trailing twelve month revenue reached US$3.7b and EPS was US$0.41. Over recent quarters the company has seen revenue move from US$532.1 million in Q1 2025 to US$1.2b in Q1 2026, while basic EPS shifted from US$0.04 to US$0.15, giving investors a cleaner read on how margins are shaping up as profitability settles in. See our full analysis for...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Australia's stock market has experienced a mix of recovery and challenges, with recent gains tempered by geopolitical tensions and domestic economic shifts. Amidst this backdrop, penny stocks—though an outdated term—remain relevant for investors seeking growth opportunities in smaller or newer companies. By focusing on those with strong financials and potential for growth, investors can discover promising prospects within this niche segment of the market.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Lundin Gold (TSX:LUG) opened 2026 with Q1 revenue of US$567.4 million and basic EPS of US$1.13, setting the tone for another data rich year of results. The company has seen quarterly revenue move from US$356.3 million in Q1 2025 to US$567.4 million in Q1 2026, with basic EPS over the same period shifting from US$0.64 to US$1.13, backed by trailing twelve month net profit margins that improved to 45.7% from 40.6%. For investors, this combination of higher earnings, rising margins and analyst...

Q1 2026 earnings snapshot Swisscom (SWX:SCMN) kicked off 2026 with Q1 revenue of CHF3.6b and basic EPS of CHF6.41, alongside net income of CHF332m, providing an early indication of how the year is starting to develop. Over recent quarters, revenue has moved between CHF2.9b in Q4 2024 and CHF3.9b in Q4 2025, while quarterly EPS has ranged from about CHF5.00 to CHF7.08, giving investors a view of how the top and bottom lines have been tracking ahead of this latest report. With trailing net...

Amplitude (AMPL) opened Q1 2026 with revenue of US$93.5 million, a basic EPS loss of US$0.17 and net income loss of US$23.3 million, against a backdrop where trailing 12 month revenue stands at US$356.8 million and basic EPS over that period is a loss of US$0.67. Over the last few quarters the company has seen revenue move from US$79.9 million in Q1 2025 to US$93.5 million in Q1 2026, while basic EPS has ranged between a loss of US$0.13 and US$0.19 across those reported periods. This keeps...

Wondering whether Xenon Pharmaceuticals at around US$56 a share still offers value, or if most of the opportunity has already been priced in. The stock has slipped 0.1% over the past week and 2.9% over the past month, yet it is still up 25.9% year to date and 57.6% over the last year. This can change how you think about both upside and risk. Recent attention on Xenon has centered on how its share price performance compares with other biotech stocks and what that says about investor...

Pattern Group (PTRN) opened 2026 with Q1 revenue of US$773.7 million and basic EPS of US$0.17, alongside net income of US$29.2 million.

CRA International (CRAI) opened 2026 with Q1 revenue of US$201 million and basic EPS of US$1.71, while trailing 12 month revenue stood at US$770.7 million and EPS at US$7.27. The company has seen quarterly revenue move from US$181.9 million and EPS of US$2.65 in Q1 2025 to US$200.0 million and EPS of US$1.71 in Q1 2026. This positions investors to weigh forecast earnings growth against a softer net margin profile. Overall, the results put the focus squarely on how much of that earnings power...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Remitly Global (RELY) opened 2026 with Q1 revenue of US$452.8 million and basic EPS of US$0.23, alongside net income of US$49.1 million, as the stock trades around US$22.79. The company has seen quarterly revenue move from US$361.6 million in Q1 2025 to US$452.8 million in Q1 2026, while basic EPS shifted from US$0.06 to US$0.23 over the same period, and trailing 12 month EPS reached US$0.51 on net income of US$105.6 million. For investors, that combination of growing top line and expanding...

Stora Enso Oyj (HLSE:STERV) opened 2026 with Q1 revenue of €2.4b and basic EPS of €0.04, setting a measured tone for its latest update. The company has seen quarterly revenue move from €2.32b in Q4 2024 to €2.36b in Q1 2025 and €2.4b in Q1 2026, while basic EPS over the same quarters shifted from a loss of €0.43 to €0.14 and then to €0.04. This puts the focus firmly on how efficiently that top line is now translating into profit. Overall, this set of numbers puts margins under the spotlight...

U.S. Physical Therapy (USPH) opened 2026 with Q1 revenue of US$196.3 million and basic EPS of a loss of US$0.12, as net income excluding extra items came in at a loss of US$1.8 million. Over the past year, the company has seen quarterly revenue move from US$181.9 million in Q1 2025 to the current US$196.3 million. Over the same period, basic EPS shifted from US$0.80 a share to a loss of US$0.12, and trailing twelve month EPS was US$0.51 on net income of US$7.7 million. These figures may...

Ligand Pharmaceuticals (LGND) opened Q1 2026 with revenue of US$51.7 million and a basic EPS loss of US$0.67, alongside a net loss of US$13.3 million. The company reported revenue of US$45.3 million and a basic EPS loss of US$2.21 in Q1 2025, compared with US$51.7 million and a basic EPS loss of US$0.67 in Q1 2026. Trailing twelve month EPS stood at US$7.87 on net income of US$153.6 million. For investors, the combination of a quarterly loss and a profitable trailing year encourages a closer...

EVERTEC (EVTC) opened 2026 with Q1 revenue of US$247.9 million and basic EPS of US$0.38, alongside trailing twelve month revenue of US$950.9 million and EPS of US$2.10 that frame the latest quarterly print. Over the past year, the company has seen revenue move from US$868.9 million to US$950.9 million on a trailing basis, while EPS shifted from US$2.02 to US$2.10, giving you a clear view of how the top and bottom lines are tracking into this result. With a trailing net profit margin of 13.9%...

Quanterix (QTRX) opened Q1 2026 with revenue of US$36.4 million and a basic EPS loss of US$0.37, alongside trailing twelve month revenue of US$145.0 million and a TTM basic EPS loss of US$2.33 that keeps the story firmly in loss making territory. Over recent quarters the company has seen revenue move between US$24.5 million and US$43.9 million while basic EPS losses have ranged from US$0.30 to US$0.77 per share. This sets a clear backdrop of growing sales paired with persistent negative...

US Foods Holding (USFD) opened Q1 2026 with revenue of US$9.6b and net income of US$116m, translating to basic EPS of US$0.53 as the company extended its recent earnings run. Over the past year, the company has seen quarterly revenue range from US$9.4b to US$10.2b and EPS move between US$0.28 and US$0.97. Trailing twelve month EPS reached US$3.02 on revenue of US$39.7b, giving investors a clearer line of sight on how earnings power is building off a relatively thin margin base. See our full...